Platform Technology Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Platform Technology Partners's BMY Position: Q2 2026 in Review
Platform Technology Partners reduced its Bristol-Myers Squibb (BMY) stake by 5.3% in Q2 2026, selling an estimated $65K and leaving 20,385 shares worth $1.17M. The position accounts for 0.19% of the portfolio, ranked #109.
Platform Technology Partners first reported a position in BMY in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.03M in Q4 2020. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Platform Technology Partners held 20,385 shares of Bristol-Myers Squibb worth $1.17M as of Q2 2026.
- Platform Technology Partners sold 1,132 Bristol-Myers Squibb shares in Q2 2026, an estimated $65K.
- Bristol-Myers Squibb made up 0.19% of Platform Technology Partners's portfolio in Q2 2026, its #109 holding.
- Platform Technology Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 25 quarters since.
- Platform Technology Partners's Bristol-Myers Squibb position peaked at $2.03M in Q4 2020.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.